Poverty and isolation are associated with worse pulmonary hypertension outcomes

PHA Canada
Apr 28, 2025
1 min read

A 2024 study looked at the association between socioeconomic disadvantage and pulmonary hypertension. In one New York hospital system, they found that patients with PH and socioeconomic disadvantage were more likely to die, even after accounting for other conditions the patients might have.

The authors suggest that improving social support, health care access, and health care affordability might reduce treatment barriers and improve outcomes. They also suggest that clinical trials include more people from underrepresented populations.

Read the CHEST 2024 conference abstract

Recent Posts

Sotatercept lowers blood volume but increases exercise ability

In a study of a relatively low-risk population of pulmonary hypertension patients, researchers began to untangle sotatercept's complex effects on exercise. Sotatercept lowered blood volume to normal l

AI May Help Predict PAH Patients' Risk of Worsening

Researchers looked at the medical records of 455 people with pulmonary arterial hypertension (PAH) to find factors associated with getting worse. Using a machine-learning computer model, they found 11

Sotatercept and cardiopulmonary comorbidities

This study from one clinic examined how well sotatercept worked in real-world patients with pulmonary arterial hypertension (PAH) who also had other heart or lung conditions, such as coronary artery d

Comments